Legal & General Group
NUTX

Legal & General Group’s Nutex Health NUTX Stock Holding History

Legal & General Group’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Sell
2,631
-1,031
-28% -$126K ﹤0.01% 2500
2025
Q4 		$603K Buy
3,662
+17
+0.5% +$2.25K ﹤0.01% 2364
2025
Q3 		$377K Hold
3,645
– – ﹤0.01% 2520
2025
Q2 		$454K Buy
+3,645
New +$471K ﹤0.01% 2472
2024
Q1 		– Sell
-316
Closed -$8.65K – 3370
2023
Q4 		$8.65K Sell
316
-821
-72% -$25.6K ﹤0.01% 3261
2023
Q3 		$34.1K Hold
1,137
– – ﹤0.01% 2906
2023
Q2 		$71.9K Buy
1,137
+309
+37% +$26.5K ﹤0.01% 2844
2023
Q1 		$125K Buy
828
+52
+7% +$10.5K ﹤0.01% 2727
2022
Q4 		$221K Buy
776
+748
+2,671% +$144K ﹤0.01% 2572
2022
Q3 		$6K Hold
28
– – ﹤0.01% 3393
2022
Q2 		$14K Buy
+28
New +$33K ﹤0.01% 3322

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Legal & General Group's NUTX Position: Q1 2026 in Review

Legal & General Group reduced its Nutex Health (NUTX) stake by 28% in Q1 2026, selling an estimated $126K and leaving 2,631 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #2500.

Legal & General Group first reported a position in NUTX in Q2 2022 and has held it in 11 quarters since. The position peaked at $603K in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Legal & General Group held 2,631 shares of Nutex Health worth $250K as of Q1 2026.
  • Legal & General Group sold 1,031 Nutex Health shares in Q1 2026, an estimated $126K.
  • Nutex Health made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2500 holding.
  • Legal & General Group first reported a position in Nutex Health in Q2 2022 and has held it in 11 quarters since.
  • Legal & General Group's Nutex Health position peaked at $603K in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.